Showing results (151-160 of 1,919) with videos related to
Sort By:
Pageof 192
Cancer Biomarkers : Section a of Disease Markers|April 29, 2017
Clinicopathological and prognostic significance of GPx2 protein expression in nasopharyngeal carcinomaC Liu, X He, X Wu, et al.Cancer Biomarkers : Section a of Disease Markers|April 29, 2017
Prognostic significance of MYCN gene amplification and protein expression in primary brain tumors: Astrocytoma and meningiomaMehrdad Asghari Estiar, Firouzeh Javan, Ali Zekri, et al.Cancer Biomarkers : Section a of Disease Markers|April 10, 2018
Elevated MACC1 expression predicts poor prognosis in small invasive lung adenocarcinomaTao Guo, Shilei Zhao, Zhuoshi Li, et al.Cancer Biomarkers : Section a of Disease Markers|April 10, 2018
Serum miR-658 induces metastasis of gastric cancer by activating PAX3-MET pathway: A population-based studyYuanyu Wu, Xiaoyu Wan, Fujian Ji, et al.Cancer Biomarkers : Section a of Disease Markers|April 18, 2018
Plasma exosome levels in non-small-cell lung cancer: Correlation with clinicopathological features and prognostic implicationsQingyun Liu, Ying Xiang, Shuai Yuan, et al.Cancer Biomarkers : Section a of Disease Markers|December 29, 2009
Diagnostic potential in prostate cancer of a panel of urinary molecular tumor markersVincenzo N Talesa, Cinzia Antognelli, Chiara Del Buono, et al.Cancer Biomarkers : Section a of Disease Markers|December 29, 2009
Oxidant-antioxidant status in Indian patients with carcinoma of posterior one-third of tongueManoj Sharma, Medha Rajappa, Guresh Kumar, et al.Cancer Biomarkers : Section a of Disease Markers|June 29, 2017
FSTL1 contributes to tumor progression via attenuating apoptosis in a AKT/GSK-3β - dependent manner in hepatocellular carcinomaWei Yang, Yaqi Wu, Cong Wang, et al.Cancer Biomarkers : Section a of Disease Markers|June 6, 2018
Studying the frequency of aberrant DNA methylation of APC, P14, and E-cadherin genes in HCV-related hepatocarcinogenesisMohamed A Mekky, Rgaa H Salama, Mahmoud F Abdel-Aal, et al.Cancer Biomarkers : Section a of Disease Markers|June 6, 2018
WITHDRAWN: Serum miR-106b upregulation predicts poor prognosis in patients with colorectal cancerYanying Zhao, Qing Ren, Kongxi ZhuPageof 192